Coenzyme A Valuation
| PPII Stock | USD 0.0002 0.00 0.00% |
Coenzyme A seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Coenzyme A from analyzing the firm fundamentals such as shares outstanding of 555.05 K, and Operating Margin of (34.92) % as well as examining its technical indicators and probability of bankruptcy.
Enterprise Value 397.2 K | Price Sales 0.0003 |
Overvalued
Today
Please note that Coenzyme A's price fluctuation is very steady at this time. Calculation of the real value of Coenzyme A is based on 3 months time horizon. Increasing Coenzyme A's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Coenzyme A is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Coenzyme Stock. However, Coenzyme A's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.0E-4 | Real 1.68E-4 | Hype 2.0E-4 | Naive 2.0E-4 |
The intrinsic value of Coenzyme A's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Coenzyme A's stock price.
Estimating the potential upside or downside of Coenzyme A helps investors to forecast how Coenzyme stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Coenzyme A more accurately as focusing exclusively on Coenzyme A's fundamentals will not take into account other important factors: Coenzyme A Cash |
|
Coenzyme A Total Value Analysis
Coenzyme A is at this time forecasted to have valuation of 397.18 K with market capitalization of 111, debt of 419.28 K, and cash on hands of 35.53 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Coenzyme A fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
397.18 K | 111 | 419.28 K | 35.53 K |
Coenzyme A Investor Information
The company recorded a loss per share of 35.31. Coenzyme A had not issued any dividends in recent years. The entity had 1:500 split on the 6th of February 2012. Based on the key measurements obtained from Coenzyme A's financial statements, Coenzyme A is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Coenzyme A Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Coenzyme signifies not a very effective usage of assets in December.Coenzyme A Profitability Analysis
The company reported the previous year's revenue of 325.46 K. Net Loss for the year was (154.78 K) with profit before overhead, payroll, taxes, and interest of 228.56 K.About Coenzyme A Valuation
An absolute valuation paradigm, as applied to Coenzyme Stock, attempts to find the value of Coenzyme A based on its fundamental and basic technical indicators. By analyzing Coenzyme A's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Coenzyme A's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Coenzyme A. We calculate exposure to Coenzyme A's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Coenzyme A's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 195.8 K | 213.7 K |
Complementary Tools for Coenzyme Stock analysis
When running Coenzyme A's price analysis, check to measure Coenzyme A's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coenzyme A is operating at the current time. Most of Coenzyme A's value examination focuses on studying past and present price action to predict the probability of Coenzyme A's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coenzyme A's price. Additionally, you may evaluate how the addition of Coenzyme A to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |